Atlas Trials

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

Clinical trial NCT05229055 · COMPLETED

Trial details

NCT number
NCT05229055
Sponsor
University of Monastir
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Pain
Start date
2023-04-15
Primary completion
2024-05-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.